Skip to content
Open·Listed in the source's current feed today

DoW Toxic Exposures Clinical Trial Award

Defense Health Agency Contracting Activity - DHACA

Go to the official application

Want a reminder before this closes?

We'll email you 3 days before the deadline. One email, then we stop.

Free. Verify your email, then we send one reminder only.

Posted
May 7, 2026
Amount
Program total $4.5M
Closes
Nov 19, 2026 (in 23 days)

See more open grant funding like this

Get alerted when new grant funding matching "toxic exposures clinical" opens, nationwide.

Checking your account…

Free includes 1 alert. Unsubscribe anytime. Your saved search uses the email schedule in your alert settings.

Classification and identifiers

Solicitation number
HT942526TERPCTA
Assistance listing (CFDA)
12.420

Amount

Program total $4.5M

Who can apply

Open to all

About this opportunity

Summary: The fiscal year 2026 (FY26) Toxic Exposures Research Program (TERP) Clinical Trial Award (CTA) mechanism supports the advancement, execution, and analysis of clinical trials with the potential to have a significant impact on the prevention, treatment, or management of symptoms, diseases or conditions associated with or resulting from military-related toxic exposures. Proposed projects may range from small proof-of-concept clinical trials (e.g., pilot, first-in-human, phase 0) designed to demonstrate the feasibility or inform the design of more advanced trials, through large-scale trials (including pragmatic clinical trials) to determine efficacy in relevant patient populations. Distinctive Features: To encourage applications that include meaningful and productive collaborations, t...

Refine this search